Is Generac stock a buy?

Following the company’s first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote, Chart, News, Analysts, Financials NYSE:GNRC).

On May 1, GNRC reported its Q1, 2024 results. The company posted Adjusted EBITDA of $127-million on Net Sales of $889-million.

“First quarter results exceeded our expectations due to strong operating margins and execution,” said CEO Aaron Jagdfeld. “Home standby generator shipments increased at a strong rate during the quarter from a softer prior year period, as field inventory continued to decline to more normalized levels. Additionally, we generated significant free cash flow during the quarter which further strengthens our confidence in executing our ‘Powering A Smarter World’ enterprise strategy. “Power security concerns have never been more apparent as the electrification of everything, deployment of energy intensive data centers, and rising long-term trend of severe weather events pressure an aging electrical grid that is increasingly reliant on intermittent renewable power generation. We believe Generac’s products and solutions are uniquely positioned to help homes and businesses solve the challenges that will result from this accelerating energy transition.”

The analyst says this is a good company with a stock that is close to fully valued.

“We continue to look for better visibility on C&I demand and the new clean energy portfolio to get more constructive post Q1 results,” he said. “Generac is a dominant category leader in back-up power, well positioned for a number of long-term secular drivers, in our view. Management has leveraged consistent cash generation from the core engine-powered portfolio to expand into adjacent markets, including higher-growth segments of energy tech (energy storage, smart home, software, etc.). We like the strategy and potential, although find risk/reward balanced at current levels.”

In a research update to clients May 1, Moore maintained his “Neutral” rating and price target of $135.00 on Generac.

The analyst thinks GNRC will post EPS of $6.28 per shares of revenue of $4.19-billion in fiscal 2024. He expects those numbers will improve toEPS of $8.02 per share on a topline of $4.62-billion in fiscal 2025.

“Our 12-month price target of $135 (unchanged) equates to an EV/EBITDA multiple of ~11x our 2025 estimate. We find the current valuation reasonable given more challenging late cycle C&I dynamics, while we await better visibility on C&I demand and the new clean energy portfolio (related investment diluting EBITDA margins by 350-400bps this year) to get more constructive,” Moore added.

Tagged with: gnrc
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

12 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

12 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

13 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

13 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

13 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

13 hours ago